Published in Circulation on December 04, 2007
Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol (2009) 1.08
Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol (Oxf) (2008) 0.92
Sex Disparities in Stroke: Women Have More Severe Strokes but Better Survival Than Men. J Am Heart Assoc (2015) 0.90
Cardiovascular functioning, personality, and the social world: the domain of hierarchical power. Neurosci Biobehav Rev (2008) 0.75
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 6.02
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39
Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med (2012) 4.18
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol (2006) 3.09
Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med (2007) 2.88
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab (2007) 2.29
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer (2006) 2.10
Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care (2007) 2.08
Marine-Lenhart syndrome. Thyroid (2003) 1.91
Sex-based differences in pain perception and treatment. Pain Med (2009) 1.82
The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab (2009) 1.71
Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) (2002) 1.64
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab (2010) 1.62
Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med (2006) 1.61
Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab (2005) 1.57
Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab (2004) 1.54
Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab (2010) 1.50
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. J Urol (2009) 1.44
Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial. J Gerontol A Biol Sci Med Sci (2013) 1.44
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab (2008) 1.40
The role of soluble interleukin-6 receptor in inflammatory diseases. Immunol Lett (2004) 1.39
Endocrine effects of marijuana. J Clin Pharmacol (2002) 1.35
Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab (2004) 1.32
Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab (2004) 1.29
Endocrine complications of androgen-deprivation therapy in men with prostate cancer. Clin Adv Hematol Oncol (2006) 1.29
Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes (2007) 1.26
Klinefelter syndrome: expanding the phenotype and identifying new research directions. Genet Med (2003) 1.21
Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection. J Acquir Immune Defic Syndr (2011) 1.17
Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). Urology (2007) 1.17
Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis. Diabetes Care (2009) 1.14
Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc (2006) 1.13
Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy. AIDS (2007) 1.09
Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am (2007) 1.09
Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use. J Neurovirol (2005) 1.08
Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol (2002) 1.07
Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr (2006) 1.07
Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin Endocrinol (Oxf) (2008) 1.00
Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. Am J Physiol Endocrinol Metab (2006) 1.00
Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study. AIDS Res Ther (2009) 0.98
New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab (2004) 0.97
Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci (2011) 0.96
The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab (2010) 0.96
Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis (2003) 0.95
Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Am J Cardiol (2006) 0.95
Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy. J Androl (2006) 0.94
Topical testosterone supplementation for the treatment of male hypogonadism. Drugs (2012) 0.94
Estradiol and inflammatory markers in older men. J Clin Endocrinol Metab (2008) 0.94
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III). Clin Endocrinol (Oxf) (2011) 0.93
Marine-Lenhart syndrome. Thyroid (2004) 0.93
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement Altern Med (2008) 0.93
Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab (2014) 0.92
Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol (Oxf) (2008) 0.92
Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study. J Androl (2008) 0.90
The effect of androgens on lipids. Curr Opin Endocrinol Diabetes Obes (2013) 0.90
Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause (2009) 0.90
SHBG, sex hormones, and inflammatory markers in older women. J Clin Endocrinol Metab (2011) 0.88
Gonadal and Adrenal Abnormalities in Drug Users: Cause or Consequence of Drug Use Behavior and Poor Health Outcomes. Am J Infect Dis (2006) 0.88
Body composition, gender, and illicit drug use in an urban cohort. Am J Drug Alcohol Abuse (2007) 0.87
Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Clin Interv Aging (2009) 0.87
Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications. Asian J Androl (2012) 0.87
Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS Body Composition substudy. AIDS Res Hum Retroviruses (2013) 0.87
Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab (2011) 0.87
Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab (2005) 0.86
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer. Arch Intern Med (2007) 0.86
Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial. J Clin Endocrinol Metab (2014) 0.86
Prevalence of low bone mineral density in a low-income inner-city population. J Bone Miner Res (2011) 0.85
Effects of testosterone on body composition of the aging male. Mech Ageing Dev (2004) 0.85
Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci (2012) 0.84
Testosterone undecanoate in the treatment of male hypogonadism. Expert Opin Pharmacother (2010) 0.84
Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism. Expert Opin Pharmacother (2005) 0.83
Clinicians' attitudes and usage of complementary and alternative integrative medicine: a survey at the Johns Hopkins Medical Institute. J Altern Complement Med (2007) 0.83
Handedness, functional cerebral hemispheric lateralization, and cognition in male-to-female transsexuals receiving cross-sex hormone treatment. Arch Sex Behav (2005) 0.83
Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male (2012) 0.83
Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J Urol (2008) 0.83
Hypothalamic-pituitary-gonadal function in men and women using heroin and cocaine, stratified by HIV status. Gend Med (2007) 0.83
Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. Curr Pharm Des (2014) 0.82
Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism. AIDS Res Ther (2014) 0.82
Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. J Androl (2010) 0.82
Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men. AIDS (2014) 0.82
The association of urinary cadmium with sex steroid hormone concentrations in a general population sample of US adult men. BMC Public Health (2008) 0.81
Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxf) (2002) 0.81
Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology (2005) 0.81
The latest options and future agents for treating male hypogonadism. Expert Opin Pharmacother (2007) 0.81
Elevated HDL cholesterol levels are associated with osteoporosis in lung transplant candidates with chronic obstructive pulmonary disease. Respir Med (2010) 0.81
Gonadal status and physical performance in older men. Aging Male (2010) 0.81
Current and future testosterone delivery systems for treatment of the hypogonadal male. Expert Opin Drug Deliv (2008) 0.80
Emerging cardiometabolic complications of androgen deprivation therapy. Aging Male (2010) 0.79